124 related articles for article (PubMed ID: 37285895)
1. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway.
Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Zhang W; Liu C; Li J; Lu Y; Li H; Zhuang J; Ren X; Wang M; Sun C
Am J Chin Med; 2022; 50(1):209-239. PubMed ID: 34983327
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA exhibits anti-inflammatory and antioxidative effects in LPS-stimulated bovine endometrial epithelial cells by activating the Nrf2 signaling pathway.
Fu K; Feng C; Shao L; Mei L; Cao R
Res Vet Sci; 2021 May; 136():220-226. PubMed ID: 33689878
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma.
Wang Y; Jin W; Wang J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760137
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
7. The Attenuation of Traumatic Brain Injury via Inhibition of Oxidative Stress and Apoptosis by Tanshinone IIA.
Huang Y; Long X; Tang J; Li X; Zhang X; Luo C; Zhou Y; Zhang P
Oxid Med Cell Longev; 2020; 2020():4170156. PubMed ID: 32454938
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.
Liao XZ; Gao Y; Huang S; Chen ZZ; Sun LL; Liu JH; Chen HR; Yu L; Zhang JX; Lin LZ
Phytother Res; 2019 Sep; 33(9):2298-2309. PubMed ID: 31268205
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
Wang WQ; Liu L; Sun HC; Fu YL; Xu HX; Chai ZT; Zhang QB; Kong LQ; Zhu XD; Lu L; Ren ZG; Tang ZY
J Hematol Oncol; 2012 Nov; 5():69. PubMed ID: 23137165
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone l exhibits anticancer effects in human endometrial carcinoma HEC-1-A cells via mitochondrial mediated apoptosis, cell cycle arrest and inhibition of JAK/STAT signalling pathway.
Li Q; Zhang J; Liang Y; Mu W; Hou X; Ma X; Cao Q
J BUON; 2018; 23(4):1092-1096. PubMed ID: 30358216
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
[TBL] [Abstract][Full Text] [Related]
13. [Tanshinone IIA alleviates lipopolysaccharide-induced renal tubular epithelial cell apoptosis by inhibiting RIP3/FUNDC1 signaling pathway].
Zhang S; Su B; Wang L; Tang S; Chen G
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1852-1857. PubMed ID: 36651254
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
Liu JJ; Zhang Y; Lin DJ; Xiao RZ
Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
[TBL] [Abstract][Full Text] [Related]
16. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.
Hu C; Zhu X; Zhang T; Deng Z; Xie Y; Yan F; Cai L
Evid Based Complement Alternat Med; 2021; 2021():5563691. PubMed ID: 34422073
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA attenuates Aβ
Zhu J; Liao S; Zhou L; Wan L
J Pharm Pharmacol; 2017 Feb; 69(2):191-201. PubMed ID: 27882565
[TBL] [Abstract][Full Text] [Related]
20. Bioactive tanshinone I inhibits the growth of lung cancer in part via downregulation of Aurora A function.
Li Y; Gong Y; Li L; Abdolmaleky HM; Zhou JR
Mol Carcinog; 2013 Jul; 52(7):535-43. PubMed ID: 22389266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
